Global insurance giant Prudential signed an exclusive agreement to use Babylon Health’s artificial intelligence (AI) based healthcare application for five million existing and new
England's NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according to the country's equality watchdog.
Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to impro
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.